Best of ASCO - 2014 Annual Meeting

 

Welcome

Palliative Care and Symptom Management

Symptoms and Survivorship

2019 ASCO Annual Meeting

Sort by: title abstract no. first author
ABSTRACT TITLEFIRST AUTHORABSTRACT NO.
“If you don’t ask, you won’t know”: Do patient-reported outcome (PRO) instruments capture the symptom experience of patients treated with immune checkpoint inhibitors (ICIs)?

Brooke Peterson Gabster

11579

A community oncology palliative program: Early results for cost and quality measures within OCM program claims data.

Adil Jamal Akhtar

11585

A double-blind, placebo-controlled randomized phase II study: Evaluating the effect of curcumin for treatment of cancer anorexia-cachexia syndrome in solid cancer patients.

Naiyarat Prasongsook

e23151

A large multicenter, randomized, double-blind, crossover study in healthy volunteers, comparing pharmacokinetics and pharmacodynamics of Sandoz proposed biosimilar pegfilgrastim with European and United States reference pegfilgrastim.

Gordon P. Otto

e23118

A phase II RCT of high-dose vitamin D supplementation and exercise for cancer treatment-induced bone loss in breast cancer patients on aromatase inhibitors.

Luke Joseph Peppone

11500

A phase II, double-blinded, randomized study using a proprietary amino acid mixture as diarrhea prevention in patients undergoing autologous stem cell transplantation (AST) for multiple myeloma (MM) and non-Hodgkin lymphoma (NHL).

Laura Luque

11607

A randomized controlled trial of a novel artificial intelligence-based smartphone application to optimize the management of cancer-related pain.

Mihir Kamdar

11514

A randomized trial comparing four-weekly versus 12-weekly administration of bone-targeted agents (denosumab, zoledronate, or pamidronate) in patients with bone metastases from either breast or castration-resistant prostate cancer.

Mark J. Clemons

11501

A randomized, double-blind, placebo-controlled phase III trial evaluating olanzapine 5 mg combined with standard antiemetic therapy for the prevention of chemotherapy-induced nausea and vomiting in patients receiving cisplatin-based chemotherapy: J-FORCE Study.

Hironobu Hashimoto

11503

Acupuncture: Real-world patient-reported outcomes of treatment-related symptoms in breast cancer survivors.

Jacqueline Zayas

e23111

An observational study to evaluate the potential of Onlife to improve chemotherapy-induced peripheral neuropathy: Final results of the STEFANO trial.

Matthias R. Zaiss

e23143

Are patients with advanced colon cancer availing of palliative care services?: Findings from a high-volume urban center.

Daniel S Jamorabo

e23101

Assessing quality of life (QoL) of patients and their caregivers on phase I clinical trials.

Gloria HJ Chan

e23130

Association of the quality of psychosocial support and quality of life in patients with chronic oncological pain.

Juan Francisco Gonzalez-Guerrero

e23113

Breast cancer patients’ quality of life: Real-world data.

Paris A. Kosmidis

e23115

Cachexia in head and neck squamous cell carcinoma (HNSCC) patients (pts) after cisplatin-based chemoradiation (CRT): A cross-sectional study.

Gilberto Castro

e23138

Clinical impact of neutropenia and febrile neutropenia in mCRC pts treated with FOLFOXIRI/bevacizumab (bev): A pooled analysis of TRIBE and TRIBE2 studies.

Daniele Rossini

11591

Clinical outcomes of manual aspiration thrombectomy for Ilio-femoral venous thrombosis in cancer patients.

Myung Ah Lee

e23145

Cognitive function in chronic lymphocytic leukemia (CLL): Examining effects of disease, treatment, and inflammation.

AnnaLynn Williams

11584

Combination of olanzapine and aprepitant in the prevention of chemotherapy-induced nausea and vomiting (CINV) in breast cancer patients.

Mukesh Shanthilal

11577

Comparison of the effectiveness of oral morphine versus oral tramadol on early pain control in opioid-naive patients with moderate cancer pain.

Ramila Shilpakar

11581

Complementary medicine and cancer: A French multicenter survey.

Florian Correard

e23127

Correlates of distress for cancer patients: Results from multi-institution use of holistic patient-reported screening tool.

Christine B. Weldon

11587

Delphi consensus on the follow-up of cancer patients with breakthrough pain under opioid treatment.

Jose Luis Gonzalez Larriba

e23135

Depression and health care utilization and costs in patients diagnosed with cancer.

Jennifer Lynne Steel

e23128

Direct oral factor Xa inhibitors for the treatment of acute cancer-associated venous thromboembolism: A systematic review and network meta-analysis.

Harry E Fuentes

e23156

Effect of free amino acids mix with medium triglycerides and Withania somnifera on cancer cachexia.

Kalyan R Gaddam

e23140

Effect of high flow oxygen on exertional dyspnea in cancer patients: A double-blind randomized clinical trial.

David Hui

11600

Effect of patient education on palliative care knowledge and acceptability of outpatient palliative care service among gynecologic oncology patients.

Ashley Graul

11583

Effect of whey protein isolate supplementation on body composition, muscle strength, and treatment tolerance in malnourished advanced cancer patients undergoing chemotherapy.

Paolo Pedrazzoli

11598

Effect on pain outcomes in patients treated for painful bone metastases with biopolar RFA: The OPuS One study.

Sandeep Bagla

11605

Effectiveness and safety of ferric carboxymaltose to treat iron deficiency anemia in cancer patients.

Burak Yasin Aktas

e23153

Effects of exercise on cancer-related fatigue and muscular strength in patients with breast cancer.

Po-Ju Lin

11507

Efficacy of different TCM treatment techniques combined with standardized step therapy for cancer pain: A network.

Peng Lv

e23131

Factors affecting sleep quality and its association to quality of life in adult Filipinos with cancer.

Amabelle Trina Borgonia Gerona

e23100

Genetic variability of tramadol pharmacokinetic genes and pain treatment outcome after breast cancer surgery.

Nikola Besic

e23133

Growth of palliative care (PC) in United States cancer centers: A national survey.

David Hui

11601

HOME palliative care-Nepal: A cell-phone/website it system.

Bishnu D. Paudel

e23134

How often do metastatic brain disease patients prescribed ten fractions of whole brain radiation therapy die without completing treatment?

Shearwood McClelland

e23146

Impact of a regular exercise program on amount of exercise and QOL metrics in patients on immune therapy.

Nicole Brenna Quenelle

TPS11636

Impact of high-dose vitamin d supplementation on short physical performance battery and bioelectrical impedance analysis in older patients with prostate cancer on ADT.

Julia Ellen Inglis

e23106

Implementation of the VA Symptom Assessment Scale (VSAS): Five-year experience.

Daphne Ruth Friedman

e23120

Improving person-centered communication of goals, proxy, and advance directives in older patients with advanced cancer: Secondary analysis from a University of Rochester NCI Community Oncology Research Program (NCORP) cluster randomized controlled trial (CRCT).

Marie Anne Flannery

11523

Interim analyses of the efficacy of a collaborative care intervention for patients diagnosed with comorbid cancer and depression.

Jennifer Lynne Steel

11599

Investigation of the efficacy of imidazolyl ethanamide pentandioic acid (IEPA) to reduce chemotherapy-induced myelosuppression (CIM) in breast cancer patients.

Frank Mayer

e23098

Is cancer associated thrombosis (CAT) an underestimated issue in oncology clinical practice? Real-world data regarding long term management of CAT.

Nikolaos Tsoukalas

e23150

Knowledge, attitude and practices regarding use of medical cannabis: A national survey among israeli oncologists.

Dan Mirelman

e23110

Learning from best scalp cooling practices in a registry: Differences in results from n>7000 patients with solid tumors.

Corina van den Hurk

11610

Lower costs of care, improved discharge disposition, and improved survival of advanced cancer patients (ACP) receiving early inpatient palliative care (PC) compared to standard oncologic care (SOC).

Christopher Daugherty

11609

Medical cannabis in cancer patients: Prevalence, efficacy, and safety.

David Macari

e23099

Mortality results from an oral oncolytic symptom management trial.

Eric Vachon

e23139

Mutational status and thromboembolic risk in lung, gastrointestinal and breast cancer patients.

Marco Platania

e23147

Naldemedine for opioid-induced constipation in patients receiving palliative care: A real-world registry study (Phase-R OIC Study).

Masaki Shimizu

11582

Non-invasive assessment of chemotherapy-induced peripheral neuropathy using neuromuscular ultrasound in breast cancer patients.

Thomas Lycan

e23152

Novel smartphone app for daily symptom reporting for active chemotherapy patients.

John Marshall

e23119

Olanzapine (OLN) versus aprepitant (APR) in patients receiving high-emetogenic chemotherapy: Final results of randomized phase II trial.

Alexey Rumyantsev

11504

Oncology Associated Symptoms and Individualized strategies (OASIS): Precision symptoms management for rural patients with advanced cancer.

Praveen Vikas

e23155

Ondansetron versus palonosetron as a marker of non-adherence to antiemetic prophylaxis guidelines in highly emetogenic chemotherapy.

Eric Roeland

e23108

Patient controlled analgesia (PCA) versus non-PCA intravenous hydromorphone titration for severe cancer pain: A randomized, controlled, multicenter, phase III trial, HMORCT09-1.

Rongbo Lin

TPS11635

Patient experience of an intervention combining nurse navigators and e-Health technologies for use of oral anticancer agents.

Marie Ferrua

e23149

Patient level factors associated with chronic opioid use in cancer patients.

Colleen Ann Cuthbert

11580

Phase 2 trial of Symptom screening with Targeted Early Palliative care (STEP) for patients with advanced cancer.

Camilla Zimmermann

11604

Physician concordance with update to ASCO guidelines for antiemetic use with carboplatin AUC ≥ 4.

Rudolph M. Navari

11595

Predictors and trajectories of fatigue in ovarian and uterine cancer.

Hanneke Poort

11603

Predictors of anxiety and depression risk among individuals with lung cancer.

Kevin Stein

e23136

Preemptive versus reactive topical clobetasol for regorafenib-induced hand-foot reactions: Results from the ReDOS trial.

Aminah Jatoi

11586

Progress and trends in the utilization and adoption of palliative care in patients with terminal gynecologic cancer in the United States: A study of 4,264 women.

Anthony Milki

11606

Randomized controlled trial (RCT) of a patient navigation (PN) intervention to increase early access to supportive care (SC) for patients with metastatic cancer in a resource-limited setting.

Enrique Soto Perez De Celis

11505

Randomized phase II study comparing mannitol with furosemide for the prevention of cisplatin-induced renal toxicity in advanced non-small cell lung cancer: The OLCSG1406 trial.

Go Makimoto

e23105

Risk factors for opioid abuse/dependence in hospitalized cancer patients in the United States.

Veli Bakalov

11589

Safety of intravenous (IV) NEPA and oral NEPA for prevention of CINV in patients (pts) with breast cancer (BC) receiving anthracycline/cyclophosphamide (AC) chemotherapy (CT).

Lee S. Schwartzberg

11594

Safety, tolerability, and PK of topical calcitriol formulation for treatment of chemotherapy-induced alopecia (CIA) in patients receiving taxane-based regimen: Final results.

Mario E. Lacouture

11608

Sex differences in adverse event reporting in SWOG chemotherapy, biologic/immunotherapy, and targeted agent cancer clinical trials.

Joseph M. Unger

11588

Single-fraction stereotactic versus standard conventional multifraction radiation for predominantly non-spine bone metastases: A randomized phase II trial.

Quynh Nguyen

11578

Study on influencing factors and survival analysis of patients with malignant tumors treated by music therapy.

Lei Hong

e23144

Supportive care medications (SCMs) and pharmacogenomics (PGx) relevance in 6,985 cancer patients (pts) undergoing distress screening.

Jai Narendra Patel

11592

Survival and safety of monosialotetrahexosylganglioside in GI cancer patients with oxaliplatin-induced peripheral neurotoxicity-result from TJMUCH-GI-001 trial.

Zhou Likun

11596

The development of a nomogram to determine the risk for inappropriate opioid use in cancer patients.

Sriram J. Yennu

11602

The effect of sukshma vyayama joint loosening yoga on aromatase inhibitor-induced arthralgia (AI) in breast cancer patients: A feasibility study conducted on Facebook.

L. Leigh Leibel

e23129

The effect of a structured weekly patient meeting on patient reported outcomes (PRO) and resource utilization for patients with metastatic breast cancer (MBC).

Margaret Q. Rosenzweig

e23116

The effect of structured exercise during chemotherapy on chemotherapy-induced peripheral neuropathy (CIPN): A role for interoceptive brain circuitry.

Ian Kleckner

11590

The efficacy and safety of exercise in metastatic solid cancer: A meta-analysis of randomized control trials.

Michelle Nadler

e23107

The efficacy of placebo for the treatment of cancer-related fatigue: A systematic review and meta-analysis.

Carmelia Maria Noia Barreto

e23157

The ESCAPADE Study: Early supportive care for advanced cancer patients, assessing care delivery and provider engagement.

Oren Hannun Levine

e23142

The ideal amount of physical activity to improve quality of life and symptoms in lung cancer patients: A systematic review.

Gilberto Castro

e23158

The impact of blinding on patient-reported outcomes (PROs) in randomized controlled trials of immune checkpoint inhibitors versus traditional chemotherapies.

James Dickerson

e23160

Therapy discontinuation processes in a gynecologic oncology population.

Catherine H. Watson

11611

Tumor mutation burden and depression in lung cancer: Association with inflammation.

Daniel Curtis McFarland

e23159

Use of remote symptom monitoring with breast cancer survivors using patient-reported outcome (PRO) measures in MyChart.

Shelby A. Terstriep

e23125

Validation of a new prognostic body composition parameter in cancer patients.

Paolo Pedrazzoli

11597